Блог – PharmCAT.NET

PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

Домашняя страница
- О сайте
Материалы
- Быстрые команды R Project
- Ссылки
Инструменты
- Рандомизационный список
Блог
Контакты
Профиль
- Войти
- Зарегистрироваться

Найти:

Свежие записи

Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
Главные ошибки при формировании базы данных в MS Excel
Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
Julia:ReplicateBE – release 0.2.0

Галерея

Human medicines European public assessment report (EPAR): Vaxneuvance, pneumococcal polysaccharide conjugate vaccine (adsorbed), Pneumococcal Infections, Date of authorisation: 13/12/2021, Revision: 5, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-09-22
Human medicines European public assessment report (EPAR): Imjudo, tremelimumab, Carcinoma, Hepatocellular, Date of authorisation: 20/02/2023, Revision: 2, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-09-22
Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Neuroendocrine Tumors, Date of authorisation: 26/09/2017, Revision: 10, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-09-22
Human medicines European public assessment report (EPAR): Adcirca (previously Tadalafil Lilly), tadalafil, Hypertension, Pulmonary, Date of authorisation: 01/10/2008, Revision: 17, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-09-22
Human medicines European public assessment report (EPAR): Procysbi, mercaptamine, Cystinosis, Date of authorisation: 05/09/2013, Revision: 16, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-09-22
Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Carcinoma, Non-Small-Cell Lung;Thyroid Neoplasms, Date of authorisation: 11/02/2021, Revision: 8, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-09-22
Human medicines European public assessment report (EPAR): Prolia, denosumab, Bone Resorption;Osteoporosis, Postmenopausal, Date of authorisation: 26/05/2010, Revision: 27, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-09-22
Human medicines European public assessment report (EPAR): Vitrakvi, larotrectinib, Abdominal Neoplasms, Date of authorisation: 19/09/2019, Revision: 10, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-09-22
Human medicines European public assessment report (EPAR): Semglee, insulin glargine, Diabetes Mellitus, Date of authorisation: 23/03/2018, Revision: 9, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-09-22
Human medicines European public assessment report (EPAR): Tenkasi (previously Orbactiv), oritavancin, Soft Tissue Infections;Skin Diseases, Bacterial, Date of authorisation: 19/03/2015, Revision: 14, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-09-22
COVID-19 Vaccines
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-09-21 By FDA
Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act
Source: FDA - What's New: Drugs RSS Feed Published on 2023-09-21 By FDA
SPIKEVAX
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-09-21 By FDA
Patent Certifications and Suitability Petitions
Source: FDA - What's New: Drugs RSS Feed Published on 2023-09-21 By FDA
Workshops, Meetings & Conferences (Biologics)
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-09-21 By FDA

Предыдущие записи

Тема: Scaffold от Danny Cooper.